Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Leukemia & Lymphoma
|
November 3, 2005
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas
B-B Park, W S Kim, J Lee, et al.
Investigational New Drugs
|
May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
K H Park, J H Sohn, S Lee, et al.
Medical Oncology (Northwood, London, England)
|
October 1, 2004
Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
S-H Lee, J Lee, J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G Bianchini, L Pusztai, T Pienkowski, et al.
Neuroscience
|
May 29, 2003
Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo
H-C Kim, K Yamada, A Nitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2018
Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial
J Ettl, R G W Quek, K-H Lee, et al.
Ophthalmology Science
|
April 7, 2023
A Multicenter Analysis of Nucleic Acid Quantification Using Aqueous Humor Liquid Biopsy in Retinoblastoma: Implications for Clinical Testing
Deborah H Im, Sarah Pike, Mark W Reid, et al.
Oncotarget
|
October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect
Esther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2020
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
J K Litton, S A Hurvitz, L A Mina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
H S Rugo, J O'Shaughnessy, F Boyle, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Leukemia & Lymphoma
|
November 3, 2005
IMVP-16/Pd followed by high-dose chemotherapy and autologous stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell lymphomas
B-B Park, W S Kim, J Lee, et al.
Investigational New Drugs
|
May 17, 2013
A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer
K H Park, J H Sohn, S Lee, et al.
Medical Oncology (Northwood, London, England)
|
October 1, 2004
Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer
S-H Lee, J Lee, J Park, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G Bianchini, L Pusztai, T Pienkowski, et al.
Neuroscience
|
May 29, 2003
Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo
H-C Kim, K Yamada, A Nitta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2018
Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial
J Ettl, R G W Quek, K-H Lee, et al.
Ophthalmology Science
|
April 7, 2023
A Multicenter Analysis of Nucleic Acid Quantification Using Aqueous Humor Liquid Biopsy in Retinoblastoma: Implications for Clinical Testing
Deborah H Im, Sarah Pike, Mark W Reid, et al.
Oncotarget
|
October 27, 2016
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect
Esther A Kleibeuker, Emmanouil Fokas, Philip D Allen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2020
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial
J K Litton, S A Hurvitz, L A Mina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2022
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
H S Rugo, J O'Shaughnessy, F Boyle, et al.
Page
of 17